Portrait Core Services Software V1.0.5 Recall
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
GE Medical Systems Information Technologies Inc is recalling 15 units of PORTRAIT CORE SERVICES SOFTWARE V1.0.5 due to a software issue affecting patient monitoring.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on September 9, 2026 and geographically references United States (MI, NY) and international. The FDA classifies this as a Class II recall, with the stated reason "Software issue may result in a loss of patient monitoring at the Hub and Central Viewer. In addition, all alarm settings could be reset to factory defaults following the update and will not follow the alarm settings previously configured for each patient or care area.", distributed us: mi, ny and australia, czech republic, finland, germany, italy, netherlands, qatar, saudi arabia, switzerland, united arab emirates, united kingdom.. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Devices.
What Happened
GE Medical Systems Information Technologies Inc initiated a voluntary recall of PORTRAIT CORE SERVICES SOFTWARE V1.0.5 after identifying a software issue that may result in a loss of patient monitoring at the Hub and Central Viewer. All alarm settings could also be reset to factory defaults following the update.
Which Products Are Affected
The recall affects PORTRAIT CORE SERVICES SOFTWARE V1.0.5, Ref# 5697353. A total of 15 units are involved, distributed in MI, NY and Australia, Czech Republic, Finland, Germany, Italy, Netherlands, Qatar, Saudi Arabia, Switzerland, United Arab Emirates, and United Kingdom. GTIN: 00195278364838. Serial numbers: SUC23080050TA, SUD22470001TA, SUD22420001TA, SUD22470010TA, SUD23390001TA, SUD23390003TA, SUD23390004TA, SUD23390009TA, SUD23390010TA, SUD22470009TA, SUD22470003TA, SUD22470004TA, SUD22470005TA, SUD23390005TA, SUD22280002TA. Recall number Z-3038-2026. Classification: Class II.
What You Should Do
Consumers should follow instructions provided in the firm's notification letter regarding the affected software.
Why This Matters
The software issue may disrupt continuous patient monitoring and alarm configurations in clinical settings.
Source
FDA recall Z-3038-2026, report date 20260902.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Medline Convenience Kits Recall Over ChloraPrep Applicator Sterility Breach (Ref. 2fe0d4)
FDA · September 16, 2026
Cardinal Health Presource Packs Recall Over CliniClean Pericare Wipes Contamination (Ref. 1adab6)
FDA · September 16, 2026
Medline Convenience Kits Recall Over BD ChloraPrep Applicator Seal Issue (Ref. 929d71)
FDA · September 16, 2026
Comparable nationwide notices (length or severity timing) 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,274 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to September 9, 2026.
Questions & Answers
Common questions about this FDA recall.